<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1099">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01638884</url>
  </required_header>
  <id_info>
    <org_study_id>2010-A00031-38</org_study_id>
    <nct_id>NCT01638884</nct_id>
  </id_info>
  <brief_title>Prospective Memory Imaging</brief_title>
  <acronym>IMPRO</acronym>
  <official_title>Cerebral Substrates of Prospective Memory in Healthy Young Adults and Disruptions in Normal Aging and Alzheimer Disease: a Study in Anatomical, Functional and Diffusion Tensor MRI.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate prospective merory (memory of intentions) in&#xD;
      healthy controls and in aMCI (amnestic Mild Cognitive Impairment) and AD (Alzheimer Disease)&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of volume change of whole brain and other structural MRI measures</measure>
    <time_frame>1 Month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral regions implicated in prospective memory observed by functional MRI</measure>
    <time_frame>1 Month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Episodic memory as measured by Cognitive Tests</measure>
    <time_frame>18 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Virtual reality evaluation of prospective memory</measure>
    <time_frame>1 Month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Group differences for each imaging and neuropsychological measurement</measure>
    <time_frame>1 Month</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Young Healthy Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Middle age Healthy Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Elderly Healthy Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild Cognitive Impairment patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Alzheimer Disease patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Memory assessment</intervention_name>
    <description>Neuropsychological tests including clinical and original tests to compare differences between each populations</description>
    <arm_group_label>Alzheimer Disease patients</arm_group_label>
    <arm_group_label>Elderly Healthy Subjects</arm_group_label>
    <arm_group_label>Middle age Healthy Subjects</arm_group_label>
    <arm_group_label>Mild Cognitive Impairment patients</arm_group_label>
    <arm_group_label>Young Healthy Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Structural MRI</intervention_name>
    <description>to compare differences between each populations</description>
    <arm_group_label>Alzheimer Disease patients</arm_group_label>
    <arm_group_label>Elderly Healthy Subjects</arm_group_label>
    <arm_group_label>Middle age Healthy Subjects</arm_group_label>
    <arm_group_label>Mild Cognitive Impairment patients</arm_group_label>
    <arm_group_label>Young Healthy Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional MRI</intervention_name>
    <description>to compare differences between each populations</description>
    <arm_group_label>Alzheimer Disease patients</arm_group_label>
    <arm_group_label>Elderly Healthy Subjects</arm_group_label>
    <arm_group_label>Middle age Healthy Subjects</arm_group_label>
    <arm_group_label>Mild Cognitive Impairment patients</arm_group_label>
    <arm_group_label>Young Healthy Subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Virtual reality / Memory assessment</intervention_name>
    <description>to compare differences between each populations</description>
    <arm_group_label>Alzheimer Disease patients</arm_group_label>
    <arm_group_label>Elderly Healthy Subjects</arm_group_label>
    <arm_group_label>Middle age Healthy Subjects</arm_group_label>
    <arm_group_label>Mild Cognitive Impairment patients</arm_group_label>
    <arm_group_label>Young Healthy Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria :&#xD;
&#xD;
          -  Education level &gt; 7 years&#xD;
&#xD;
          -  Native language: French&#xD;
&#xD;
          -  Beck &lt; 7&#xD;
&#xD;
          -  Medical, neurological, neuropsychological and neuroradiological depth in accordance&#xD;
             with the criteria for inclusion and exclusion-specific population, that is to say:&#xD;
&#xD;
               -  Young Healthy Subjects: between 18 and 44 years old;&#xD;
&#xD;
               -  Middle age Healthy Subjects: between 45 and 69 years old; without memory&#xD;
                  complaints, normal performances compared to the age and the educational level for&#xD;
                  all tests of the diagnostic battery.&#xD;
&#xD;
               -  Elderly Healthy Subjects: over 70 years old, without memory complaints, normal&#xD;
                  performances compared to the age and the educational level for all tests of the&#xD;
                  diagnostic battery.&#xD;
&#xD;
               -  MCI patients: over 50 years old, presenting the current criteria for amnestic MCI&#xD;
                  including: i) memory complaint, ii) deficits of the episodic memory (lower&#xD;
                  performance of at least 1 SD from the norm for age and cultural level for one or&#xD;
                  more scores of episodic memory and iii) normal performances compared to the age&#xD;
                  and the educational level of all other cognitive functions as memory, including&#xD;
                  tests to assess cognitive abilities.&#xD;
&#xD;
               -  Alzheimer's patients: over 50 years old, presenting the standard criteria of&#xD;
                  NINCDS-ADRDA probable Alzheimer's disease, including abnormal global cognitive&#xD;
                  function and deficits in at least two cognitive domains identified by the&#xD;
                  diagnostic battery and a mild to moderate Alzheimer's disease (MMSE ≥ 18).&#xD;
&#xD;
        Exclusion Criteria :&#xD;
&#xD;
          -  The sudden onset of cognitive impairments (as opposed to their slow and gradual&#xD;
             installation in Alzheimer's disease)&#xD;
&#xD;
          -  A chronic neurological, psychiatric, endocrine, hepatic or infectious complaint&#xD;
&#xD;
          -  A history of major disease (a lung, heart, metabolic, hematologic, endocrine disease&#xD;
             or a severe cancer);&#xD;
&#xD;
          -  A medication that may interfere with memory or metabolic measures&#xD;
&#xD;
          -  A alcohol or drugs abuse&#xD;
&#xD;
          -  claustrophobia, metallic object in the body&#xD;
&#xD;
          -  A predominantly left-hand (score below 50% in Edinburgh Inventory).&#xD;
&#xD;
          -  Protected adults, and persons not affiliated with a social security system will not&#xD;
             participate in this study.&#xD;
&#xD;
          -  Pregnant or suckling women&#xD;
&#xD;
          -  The inclusion of a participant in another biomedical research protocol (during the&#xD;
             study or within 12 months before inclusion)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent de La Sayette, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien Chavant</last_name>
    <phone>+33231065495</phone>
    <email>memoire-recherche.caen@inserm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>GIP Cyceron</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>MRSH - University of Caen</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Côte de Nacre</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <study_first_submitted>July 10, 2012</study_first_submitted>
  <study_first_submitted_qc>July 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2012</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prospective Memory</keyword>
  <keyword>Healthy Aging</keyword>
  <keyword>Alzheimer Disease</keyword>
  <keyword>Brain Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

